Abstract
POLYCYCLIC hydrocarbons such as benzo(a)pyrene (BP) are prevalent environmental contaminants3 and are increasingly suspect as human carcinogens. They are routinely used as tumour agents in laboratory animals1 and in tissue culture assays2. These compounds are produced by the incomplete combustion of carbonaceous material such as fossil fuels used for transportation and industrial energy production. They are biologically inactive as parent compounds and require metabolic activation in tissue to produce a tumourigenically active species of the molecule. Activation is accomplished through the drug metabolising monooxygenase enzymes containing cytochrome P450 (refs 4–6), and activate the parent carcinogen to an intermediate epoxide7,8 which readily alkylates cellular macromolecules.
Similar content being viewed by others
References
Publs publ. Hlth Serv., Wash. No. 149 (1973).
Heidelberger, C. Ann. Review Biochem. 44, 79 (1975).
Committee on Biologic Effects of Atmospheric Pollutants. (National Academy of Sciences, Washington, D.C., 1972).
Gelboin, H. V. Cancer Res. 10, 1 (1967).
Conney, A. H. Pharmacol. Rev. 19, 317 (1967).
Hebert, D. W., Robinson, J. R., Niwa, A., Kumaki, K. & Poland, A. P. J. Cell Physiol. 85, 393 (1975).
Selkirk, J. K., Croy, R. G. & Gelboin, H. V. Arch. biochem. Biophys. 168, 322 (1975).
Sims, P. & Grover, P. L. Adv. Cancer Res. 20, 165 (1974).
Haugen, D. A., Coon, M. J. & Nebert, D. W. J. biol. Chem. 251, 1817 (1976).
Sims, P., Grover, P. L., Swaisland, A., Pal, K. & Hewer, A. Nature 252, 326 (1974).
Weinstein, I. B., Jeffrey, A. M., Hennette, K. W., Blobstein, S. H., Harvey, R. G., Harris, C., Autrup, H., Kasai, H. & Nakanishi, K. Science 193, 592 (1976).
Yang, S. K., McCourt, D., Roller, P. P. & Gelboin, H. V. Proc. natn. Acad. Sci. U.S.A. 73, 2494 (1976).
King, H. W. S., Osborne, M. R., Beland, F. A., Harvey, R. G. & Brookes, P. Proc. natn. Acad. Sci. U.S.A. 73, 2679 (1976).
Selkirk, J. K., Croy, R. G., Wiebel, F. J. & Gelboin, H. V. Cancer Res. 35, 4476 (1976).
Ames, B. N., McCann, J. & Yamasaki, E. Mutat. Res. 31, 347 (1975).
Kuroki, T., Drevon, C. & Montesano, R. Cancer Res. 37, 1044 (1977).
Kinoshita, N., Shears, B. & Gelboin, H. V. Cancer Res. 33, 1936 (1973).
Selkirk, J. K., Croy, R. G. & Gelboin, H. V. Science 184, 169 (1974).
Baird, W. M., Chern, C. J. & Diamond, L. Cancer Res. 37, 3190 (1977).
Cohen, G. M. & Moore, B. P. Biochem. Pharmacol. 25, 1623 (1976).
Huberman, E. & Sachs, L. Int. J. Cancer 13, 326 (1974).
Huberman, E. & Sachs, L. Proc. natn. Acad. Sci. U.S.A. 73, 188 (1976).
Nagata, C., Tagashira, Y. & Kodama, M. in Chemical Carcinogenesis (eds P. O. P. Ts'o & J. A. DiPaolo), ch. 2, 87–111 (New York, Dekker, 1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SELKIRK, J. Divergence of metabolic activation systems for short-term mutagenesis assays. Nature 270, 604–607 (1977). https://doi.org/10.1038/270604a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/270604a0
- Springer Nature Limited
This article is cited by
-
Species specificity affects the choice of S9 preparations for use in the hamster embryo cell transformation system
In Vitro (1984)
-
Current trends in safety testing and toxicological research
Naturwissenschaften (1982)